Kiromic Biopharma Inc (KRBP) — Strategic Asset Allocation Index
Kiromic Biopharma Inc (KRBP) has a Strategic Asset Allocation Index of 3819.1% as of September 2022. Strategic assets (PP&E of $10.85 Million plus long-term investments of $-) total $10.85 Million, measured against net assets of $284.10K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Kiromic Biopharma Inc Strategic Asset Allocation Index (2018–2021)
This chart shows how Kiromic Biopharma Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2021. As of September 2022, the index stands at 3819.1%, representing strategic assets of $10.85 Million against net assets of $284.10K USD. Explore how efficiently does Kiromic Biopharma Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Kiromic Biopharma Inc (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Kiromic Biopharma Inc from 2018 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Kiromic Biopharma Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.3% | $3.63 Million | $3.63 Million | $- | $27.32 Million | ▼ -4.9 pp |
| 2020 | 18.2% | $2.07 Million | $2.07 Million | $- | $11.36 Million | ▼ -11.5 pp |
| 2019 | 29.7% | $587.90K | $587.90K | $- | $1.98 Million | ▼ -82.6 pp |
| 2018 | 112.3% | $298.00K | $298.00K | $- | $265.30K | — |